ILUVIEN

This brand name is authorized in United States. It is also authorized in Austria, Finland, France, Ireland, Netherlands, New Zealand, Poland, Spain, UK.

Active ingredients

The drug ILUVIEN contains one active pharmaceutical ingredient (API):

1
UNII 0CD5FD6S2M - FLUOCINOLONE ACETONIDE
 

Fluocinolone acetonide is a synthetic fluorinated corticosteroid with anti-inflammatory, antipruritic, and vasoconstrictive properties.

 
Read more about Fluocinolone

Medication package inserts

Below package inserts are available for further reading:

Document Type Information Source  
 ILUVIEN Intravitreal implant MPI, EU: SmPC Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
S01BA15 Fluocinolone acetonide S Sensory organs → S01 Ophthalmologicals → S01B Antiinflammatory agents → S01BA Corticosteroids, plain
Discover more medicines within S01BA15

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
ES Centro de información online de medicamentos de la AEMPS 76832
FI Lääkealan turvallisuus- ja kehittämiskeskus 506248
FR Base de données publique des médicaments 61412157
GB Medicines & Healthcare Products Regulatory Agency 225161
NL Z-Index G-Standaard, PRK 204315
NZ Medicines and Medical Devices Safety Authority 21705
PL Rejestru Produktów Leczniczych 100333342
US FDA, National Drug Code 68611-190

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.